01399nas a2200193   4500000000100000008004100001653003000042653002100072653002000093653002000113100001200133700001200145700001900157700001200176245014100188856017900329490000700508520069000515       2024                            d10aErythema Nodosom Leprosum10aHansen's disease10aNaranjo Scaling10aType 2 reaction1 aKumar H1 aKumar S1 aKumar Mahato S1 aSingh H00aErythema nodosum leprosum (Type 2 Reaction) in a Patient with Hansen's Disease from a Tertiary care hospital in Jharkhand: A case report  uhttps://biomedpharmajournal.org/vol17no1/erythema-nodosum-leprosum-type-2-reaction-in-a-patient-with-hansens-disease-from-a-tertiary-care-hospital-in-jharkhand-a-case-report/0 v173 a<p>Lepra Reactions (LR) are inflammatory conditions with immune mediators that are highly morbid. Patients with the lepromatous end of the leprosy spectrum (BL-LL) are the only ones that develop type-2 LR. 90% of the time, it happens during or right after treatment, usually within two years. Here, we present a type-2 LR case. The sixty-year-old woman who was diagnosed with lepromatous leprosy (LL) after developing a hypopigmented skin lesion six months prior. She was treated twice at our hospital over the course of the previous six months after developing type-2 LR, which manifested as recurrent fever episodes, polyarthritis, erythema nodosum, and mononeuritis multiplex.</p>